SCHEMBL10697252

SCHEMBL10697252

Cn1c(/C=C/C(O)CC(=O)CC(=O)O)c(-c2ccc(F)cc2)c2cccnc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 5/20 0.48
CYP2C9 P11712 4/20 0.48
SIRT6 Q8N6T7 2/20 0.48
NR4A2 P43354 2/20 0.48
PDE4D Q08499 2/20 0.48
ABCC3 O15438 1/20 0.48
ABCB11 O95342 1/20 0.48
PGR P06401 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
RXRA P19793 1/20 0.48
TBXA2R P21731 1/20 0.48
CCKAR P32238 1/20 0.48
ADRA1A P35348 1/20 0.48
PTGS2 P35354 1/20 0.48
SLC10A1 Q14973 1/20 0.48
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10697261 1.00 HMGCR (0.48) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10393707 0.89 CYP2C9 (0.41) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10393708 0.89 CYP2C9 (0.41) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10393709 0.89 CYP2C9 (0.41) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10696646 0.87 HMGCR (0.64) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10696630 0.87 HMGCR (0.64) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10394086 0.80 HMGCR (0.51) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10394088 0.80 HMGCR (0.51) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL10394085 0.80 HMGCR (0.51) HMGCRCYP2C9SIRT6NR4A2PDE4D
SCHEMBL9763509 0.77 HMGCR (0.61) HMGCRCYP2C9SIRT6NR4A2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0265640-A2 Azaindole and indolizine derivatives, processes for their production and their use as pharmaceuticals SANDOZ AG (CH) 1988-05-04 EP disclosed